Somewhat Favorable Media Coverage Somewhat Unlikely to Impact Milestone Scientific (MLSS) Share Price
News articles about Milestone Scientific (NASDAQ:MLSS) have trended somewhat positive recently, according to Accern. The research firm identifies negative and positive news coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Milestone Scientific earned a daily sentiment score of 0.14 on Accern’s scale. Accern also gave news stories about the company an impact score of 45.7865719771005 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.
Shares of Milestone Scientific (NASDAQ:MLSS) traded down 3.85% during mid-day trading on Monday, hitting $1.25. 37,339 shares of the company were exchanged. The firm’s market capitalization is $41.24 million. The company’s 50-day moving average price is $1.25 and its 200-day moving average price is $1.37. Milestone Scientific has a 12-month low of $1.08 and a 12-month high of $2.19.
Separately, Maxim Group reissued a “buy” rating and issued a $4.00 price target on shares of Milestone Scientific in a report on Tuesday, August 15th.
Milestone Scientific Company Profile
Milestone Scientific Inc (Milestone) is engaged in providing computer-controlled injection technologies and solutions for the medical and dental markets. The Company uses its CompuFlo technology for the delivery of medicaments. The CompuFlo pressure or force Computer-Controlled Local Anesthetic Delivery (C-CLAD) technology is a medical technology for the delivery of drugs, anesthetics and other medicaments into various tissue types.
Receive News & Ratings for Milestone Scientific Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific Inc. and related companies with MarketBeat.com's FREE daily email newsletter.